![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Research Papers
Howard Hughes Medical Institute, Department of Medicine, University of California, San Francisco 94143.
Abstract
The human immunodeficiency virus (HIV-1)-encoded trans-activator (tat) increases HIV gene expression and replication. Previously, we demonstrated that tat facilitates elongation of transcription through the HIV-1 long terminal repeat (LTR) and that short transcripts corresponding to prematurely terminated RNA are released and accumulate in the absence of tat. Here, using a transient expression assay, we tested clustered and compensatory mutations, as well as 3' deletions, in the trans-acting responsive region (tar) and observed that the primary sequence in the loop and secondary structure in the stem of the stem-loop in tar are required for trans-activation by tat. Insertions in the 5' region of tar revealed that tar must be near the site of HIV-1 initiation of transcription for trans-activation by tat. Deletions (3') and an insertion in tar demonstrated that an intact stem-loop is required for the recovery of prematurely terminated transcripts. Short and full-length transcripts were observed also with HIV type 2 (HIV-2) in the absence and presence of tat, respectively. We conclude that an intact stem-loop in tar is essential for trans-activation by tat and that initiation of transcription by HIV-1 promoter factors and elongation of transcription by tat are coupled.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  Y. Zeng, X. Zhang, Z. Huang, L. Cheng, S. Yao, D. Qin, X. Chen, Q. Tang, Z. Lv, L. Zhang, et al. Intracellular Tat of Human Immunodeficiency Virus Type 1 Activates Lytic Cycle Replication of Kaposi's Sarcoma-Associated Herpesvirus: Role of JAK/STAT Signaling J. Virol., March 1, 2007; 81(5): 2401 - 2417. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Pachulska-Wieczorek, K. J. Purzycka, and R. W. Adamiak New, extended hairpin form of the TAR-2 RNA domain points to the structural polymorphism at the 5' end of the HIV-2 leader RNA Nucleic Acids Res., May 31, 2006; 34(10): 2984 - 2997. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sun, T. Soos, V. N. KewalRamani, K. Osiecki, J. H. Zheng, L. Falkin, L. Santambrogio, D. R. Littman, and H. Goldstein CD4-Specific Transgenic Expression of Human Cyclin T1 Markedly Increases Human Immunodeficiency Virus Type 1 (HIV-1) Production by CD4+ T Lymphocytes and Myeloid Cells in Mice Transgenic for a Provirus Encoding a Monocyte-Tropic HIV-1 Isolate J. Virol., February 15, 2006; 80(4): 1850 - 1862. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. N. Leonard and D. V. Schaffer Computational Design of Antiviral RNA Interference Strategies That Resist Human Immunodeficiency Virus Escape J. Virol., February 1, 2005; 79(3): 1645 - 1654. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Surabhi and R. B. Gaynor RNA Interference Directed against Viral and Cellular Targets Inhibits Human Immunodeficiency Virus Type 1 Replication J. Virol., November 13, 2002; 76(24): 12963 - 12973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Darfeuille, A. Arzumanov, S. Gryaznov, M. J. Gait, C. Di Primo, and J.-J. Toulme Loop-loop interaction of HIV-1 TAR RNA with N3' right-arrow P5' deoxyphosphoramidate aptamers inhibits in vitro Tat-mediated transcription PNAS, July 23, 2002; 99(15): 9709 - 9714. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Kaushik, A. Basu, P. Palumbo, R. L. Myers, and V. N. Pandey Anti-TAR Polyamide Nucleotide Analog Conjugated with a Membrane-Permeating Peptide Inhibits Human Immunodeficiency Virus Type 1 Production J. Virol., March 19, 2002; 76(8): 3881 - 3891. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Bourgeois, Y. K. Kim, M. J. Churcher, M. J. West, and J. Karn Spt5 Cooperates with Human Immunodeficiency Virus Type 1 Tat by Preventing Premature RNA Release at Terminator Sequences Mol. Cell. Biol., February 15, 2002; 22(4): 1079 - 1093. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. E. Jeeninga, M. Hoogenkamp, M. Armand-Ugon, M. de Baar, K. Verhoef, and B. Berkhout Functional Differences between the Long Terminal Repeat Transcriptional Promoters of Human Immunodeficiency Virus Type 1 Subtypes A through G J. Virol., April 15, 2000; 74(8): 3740 - 3751. [Abstract] [Full Text]
|
|
|
|
|
|
P. D. Bieniasz, T. A. Grdina, H. P. Bogerd, and B. R. Cullen Highly Divergent Lentiviral Tat Proteins Activate Viral Gene Expression by a Common Mechanism Mol. Cell. Biol., July 1, 1999; 19(7): 4592 - 4599. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I Choudhury, J Wang, S Stein, A Rabson, and M. Leibowitz Translational effects of peptide antagonists of Tat protein of human immunodeficiency virus type 1 J. Gen. Virol., March 1, 1999; 80(3): 777 - 782. [Abstract]
|
|
|
|
|
|
J. L. Clever, D. A. Eckstein, and T. G. Parslow Genetic Dissociation of the Encapsidation and Reverse Transcription Functions in the 5' R Region of Human Immunodeficiency Virus Type 1 J. Virol., January 1, 1999; 73(1): 101 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Majello, G. Napolitano, P. De Luca, and L. Lania Recruitment of Human TBP Selectively Activates RNA Polymerase II TATA-dependent Promoters J. Biol. Chem., June 26, 1998; 273(26): 16509 - 16516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. El Kharroubi, G. Piras, R. Zensen, and M. A. Martin Transcriptional Activation of the Integrated Chromatin-Associated Human Immunodeficiency Virus Type 1 Promoter Mol. Cell. Biol., May 1, 1998; 18(5): 2535 - 2544. [Abstract] [Full Text]
|
|
|
|
 |
|
 T. P. Cujec, H. Okamoto, K. Fujinaga, J. Meyer, H. Chamberlin, D. O. Morgan, and B. M. Peterlin The HIV transactivator TAT binds to the CDK-activating kinase and activates the phosphorylation of the carboxy-terminal domain of RNA polymerase II Genes & Dev., October 15, 1997; 11(20): 2645 - 2657. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. F. Garcia-Martinez, D. Ivanov, and R. B. Gaynor Association of Tat with Purified HIV-1 and HIV-2 Transcription Preinitiation Complexes J. Biol. Chem., March 14, 1997; 272(11): 6951 - 6958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Zhou and P. A. Sharp Tat-SF1: Cofactor for Stimulation of Transcriptional Elongation by HIV-1 Tat Science, October 25, 1996; 274(5287): 605 - 610. [Abstract] [Full Text]
|
|
|
|
|
|
L S Tiley, S J Madore, M H Malim, and B R Cullen The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes & Dev., November 1, 1992; 6(11): 2077 - 2087. [Abstract] [PDF]
|
|
|
|
|
|
A Krumm, T Meulia, M Brunvand, and M Groudine The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes & Dev., November 1, 1992; 6(11): 2201 - 2213. [Abstract] [PDF]
|
|
|
|
|
|
M. Hsu, A. Schutt, M Holly, L. Slice, M. Sherman, D. Richman, M. Potash, and D. Volsky Inhibition of HIV replication in acute and chronic infections in vitro by a Tat antagonist Science, December 20, 1991; 254(5039): 1799 - 1802. [Abstract] [PDF]
|
|
|
|
|
|
C D Southgate and M R Green The HIV-1 Tat protein activates transcription from an upstream DNA-binding site: implications for Tat function. Genes & Dev., December 1, 1991; 5(12b): 2496 - 2507. [Abstract] [PDF]
|
|
|
|
|
|
C T Sheline, L H Milocco, and K A Jones Two distinct nuclear transcription factors recognize loop and bulge residues of the HIV-1 TAR RNA hairpin. Genes & Dev., December 1, 1991; 5(12b): 2508 - 2520. [Abstract] [PDF]
|
|
|
|
|
|
F Wu, J Garcia, D Sigman, and R Gaynor tat regulates binding of the human immunodeficiency virus trans-activating region RNA loop-binding protein TRP-185. Genes & Dev., November 1, 1991; 5(11): 2128 - 2140. [Abstract] [PDF]
|
|
|
|
|
|
A Gatignol, A Buckler-White, B Berkhout, and K. Jeang Characterization of a human TAR RNA-binding protein that activates the HIV-1 LTR Science, March 29, 1991; 251(5001): 1597 - 1600. [Abstract] [PDF]
|
|
|
|
|
|
B J Calnan, S Biancalana, D Hudson, and A D Frankel Analysis of arginine-rich peptides from the HIV Tat protein reveals unusual features of RNA-protein recognition. Genes & Dev., February 1, 1991; 5(2): 201 - 210. [Abstract] [PDF]
|
|
|
|
|
|
R Ratnasabapathy, M Sheldon, L Johal, and N Hernandez The HIV-1 long terminal repeat contains an unusual element that induces the synthesis of short RNAs from various mRNA and snRNA promoters. Genes & Dev., December 1, 1990; 4(12a): 2061 - 2074. [Abstract] [PDF]
|
|
|
|
|
|
M F Laspia, A P Rice, and M B Mathews Synergy between HIV-1 Tat and adenovirus E1A is principally due to stabilization of transcriptional elongation. Genes & Dev., December 1, 1990; 4(12b): 2397 - 2408. [Abstract] [PDF]
|
|
|
|
|
|
H Mitsuya, R Yarchoan, and S Broder Molecular targets for AIDS therapy Science, September 28, 1990; 249(4976): 1533 - 1544. [Abstract] [PDF]
|
|
|
|
|
|
S Roy, U Delling, C H Chen, C A Rosen, and N Sonenberg A bulge structure in HIV-1 TAR RNA is required for Tat binding and Tat-mediated trans-activation. Genes & Dev., August 1, 1990; 4(8): 1365 - 1373. [Abstract] [PDF]
|
|
|
|
|
|
P Nelbock, P. Dillon, A Perkins, and C. Rosen A cDNA for a protein that interacts with the human immunodeficiency virus Tat transactivator Science, June 29, 1990; 248(4963): 1650 - 1653. [Abstract] [PDF]
|
|
